Intelliseq
Krak├│w
About Intelliseq
Intelliseq is a genome informatics company developing bioinformatics tools for diagnostics, therapy, and prevention based on genetic data. Currently, bioinformatics systems in laboratories are not ready for genomics at scale. The analysis process of already sequenced genomes is now mostly expensive and labor-intensive. In response to this problem the company created a cloud-based platform called IntelliseqFlow that allows for automated bioinformaticianless generation of result reports that accelerates the entire diagnostic process and reduces the costs that the laboratory had to deal with so far. IntelliseqFlow translates raw DNA data into final reports automatically, making the analysis step fast, simple, cost-effective, and user-friendly. Allows users to choose ready-to-use workflows for PGx, Germline Disorders, Somatic Cancer, and Polygenic Risk Scoring, all wrapped up in one user-friendly platform. It comprises AI-based algorithms, easy-to-operate pipelines, customized workflows, and APIs that make it simple to integrate its engine with laboratory information systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $7.1M
- Last round: Series Unknown (Mar 2025)
- Website: intelliseq.com
- Phone: +48 696622014
Industries & Categories
Analytics, Artificial Intelligence (AI), Biotechnology, Health Care, Software
Social Profiles
Canonical: https://fsome.com/organization/intelliseq-78810 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.